H. Knobel

发表

M. Leal, J. Moltó, F. Pulido, 2011, Clinical drug investigation.

HIV testing history and access to treatment among migrants living with HIV in Europe

A. Copas, B. Ledergerber, S. Corrao, 2018, Journal of the International AIDS Society.

High prevalence of extended-spectrum beta-lactamase-producing enterobacteriaceae in bacteremia after transrectal ultrasound-guided prostate biopsy: a need for changing preventive protocol.

J. Lorente, J. Horcajada, M. Salvadó, 2009, Urology.

Body composition and adipokines changes after initial treatment with darunavir-ritonavir plus either raltegravir or tenofovir disoproxil fumarate-emtricitabine: A substudy of the NEAT001/ANRS143 randomised trial

A. Mocroft, C. Katlama, P. Reiss, 2019, PloS one.

Response to highly active antiretroviral therapy in HIV-infected patients aged 60 years or older after 24 months follow-up.

H. Knobel, A. Diez, J. Gimeno, 2001, AIDS.

Bone density, microarchitecture, and tissue quality after 1 year of treatment with tenofovir disoproxil fumarate

A. Díez-Pérez, T. Brown, N. Garcia-Giralt, 2018, AIDS.

Adherence and effectiveness of highly active antiretroviral therapy.

J. Pedro-Botet, H. Knobel, A. Diez, 1998, Archives of internal medicine.

Efficacy and Safety of Switching From Boosted Lopinavir to Boosted Atazanavir in Patients With Virological Suppression Receiving a LPV/r-Containing HAART: The ATAZIP Study

D. Podzamczer, B. Clotet, J. Gatell, 2009, Journal of acquired immune deficiency syndromes.

Spanish HIV-1-Infected Long-Term Nonprogressors of More Than 15 Years Have an Increased Frequency of the CX3CR1 249I Variant Allele

S. Mallal, C. Gutiérrez, C. Richart, 2005, Journal of acquired immune deficiency syndromes.

Bone Density, Microarchitecture, and Tissue Quality After Long-Term Treatment With Tenofovir/Emtricitabine or Abacavir/Lamivudine

A. Díez-Pérez, H. Knobel, D. Molina-Morant, 2017, Journal of acquired immune deficiency syndromes.

Systemic Bartonella henselae infection and Crohn's disease treatment with infliximab.

M. Andreu, J. Horcajada, H. Knobel, 2012, Inflammatory bowel diseases.

Prevalence and Factors Associated with Vitamin D Deficiency and Hyperparathyroidism in HIV-Infected Patients Treated in Barcelona

H. Knobel, A. Diez, A. Guelar, 2012, ISRN AIDS.

Chronic kidney disease prevalence and risk factors among HIV-infected patients.

H. Knobel, E. Rodríguez, A. Guelar, 2008, Journal of acquired immune deficiency syndromes.

Subclinical kidney disease in HIV-infected patients

H. Knobel, A. Guelar, A. González, 2008 .

Predictive factors of renal impairment in HIV-infected patients on antiretroviral therapy: Results from the VACH longitudinal cohort study.

J. Blanco, A. Antela, R. Palacios, 2019, Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia.

Predictive factors of renal impairment in HIV-infected patients on antiretroviral therapy: Results from the VACH longitudinal cohort study

J. Blanco, A. Antela, R. Palacios, 2019, Nefrología (English Edition).

A Simplification Trial Switching From Nucleoside Reverse Transcriptase Inhibitors to Once-Daily Fixed-Dose Abacavir/Lamivudine or Tenofovir/Emtricitabine in HIV-1-Infected Patients With Virological Suppression

D. Podzamczer, B. Clotet, J. Miro, 2009, Journal of acquired immune deficiency syndromes.

Drug–drug interactions of telaprevir and boceprevir in HCV‐monoinfected and HIV/HCV‐coinfected patients can modify the adherence

R. Solá, M. García-Retortillo, J. Carrión, 2015, Liver international : official journal of the International Association for the Study of the Liver.

Subclinical Carotid Atherosclerosis in HIV-Infected Patients: Role of Combination Antiretroviral Therapy

C. Jericó, H. Knobel, J. López-Colomés, 2006, Stroke.

Lack of Association of SDF-1 3′A Variant Allele With Long-Term Nonprogressive HIV-1 Infection Is Extended Beyond 16 Years

C. Gutiérrez, C. Richart, M. Broch, 2005, Journal of acquired immune deficiency syndromes.

Effect of Genetic Variants of CCR2 and CCL2 on the Natural History of HIV-1 Infection: CCL2-2518GG Is Overrepresented in a Cohort of Spanish HIV-1-Infected Subjects

Felipe García, M. Plana, J. Gatell, 2007, Journal of acquired immune deficiency syndromes.

[Adherence to very active antiretroviral treatment: impact of individualized assessment].

H. Knobel, A. Diez, J. Gimeno, 1999, Enfermedades infecciosas y microbiologia clinica.

Consensus document on enhancing medication adherence in patients with the human immunodeficiency virus receiving antiretroviral therapy.

Rosa Polo, H. Knobel, R. Polo, 2020, Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria.

Abacavir/Lamivudine plus Rilpivirine Is an Effective and Safe Strategy for HIV-1 Suppressed Patients: 48 Week Results of the SIMRIKI Retrospective Study

D. Podzamczer, E. Ribera, S. Moreno, 2016, PloS one.

Abacavir/lamivudine plus darunavir/ritonavir in routine clinical practice: a multicentre experience in antiretroviral therapy-naive and -experienced patients.

D. Podzamczer, B. Clotet, V. Moreno, 2014, The Journal of antimicrobial chemotherapy.

Hepatic safety of efavirenz in HIV/hepatitis C virus-coinfected patients with advanced liver fibrosis.

B. Clotet, J. Mallolas, M. Crespo, 2012, The Journal of infection.

Nevirapine-containing regimens in HIV-infected naive patients with CD4 cell counts of 200 cells/μl or less

D. Podzamczer, E. Ribera, E. Ferrer, 2004, AIDS.

Delayed diagnosis of tuberculosis in persons living with HIV in Eastern Europe: associated factors and effect on mortality—a multicentre prospective cohort study

A. Mocroft, O. Kirk, J. González, 2021, BMC Infectious Diseases.

Failure of Cetirizine to Prevent Nevirapine-Associated Rash: A Double-Blind Placebo-Controlled Trial for the GESIDA 26/01 Study

J. Miro, J. Blanco, E. Ribera, 2004, Journal of acquired immune deficiency syndromes.

Are nonnucleoside analogue-based regimens better than protease inhibitor-based regimens for nonadherent HIV-infected patients?

H. Knobel, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Impact of Adherence and Highly Active Antiretroviral Therapy on Survival in HIV‐Infected Patients

J. Caylà, H. Knobel, P. G. de Olalla, 2002, Journal of acquired immune deficiency syndromes.

Polymorphism of RANTES Chemokine Gene Promoter Is Not Associated With Long-Term Nonprogressive HIV-1 Infection of More Than 16 Years

C. Gutiérrez, C. Richart, M. Broch, 2006, Journal of acquired immune deficiency syndromes.

HIV Epidemiology and Prevention in Southwestern China: Trends from 1996-2017

D. Podzamczer, B. Clotet, H. Xing, 2018, Current HIV research.

Risk factors for multidrug-resistant Pseudomonas aeruginosa acquisition. Impact of antibiotic use in a double case–control study

X. Castells, M. Sala, F. Alvarez-lerma, 2010, European Journal of Clinical Microbiology & Infectious Diseases.

Intracerebral Haemorrhage in AIDS

J. Roquer, E. Palomeras, H. Knobel, 1998, Cerebrovascular Diseases.

Effectiveness and Safety of Abacavir, Lamivudine, and Zidovudine in Antiretroviral Therapy-Naive HIV-Infected Patients: Results From a Large Multicenter Observational Cohort

D. Podzamczer, J. Gatell, V. Soriano, 2006, Journal of acquired immune deficiency syndromes.

Analysis of the costs and cost-effectiveness of the guidelines recommended by the 2018 GESIDA/Spanish National AIDS Plan for initial antiretroviral therapy in HIV-infected adults.

E. Negredo, J. Miro, J. Gatell, 2019, Enfermedades infecciosas y microbiologia clinica.

HIV infection is strongly associated with hip fracture risk, independently of age, gender, and comorbidities: A population‐based cohort study

A. Díez-Pérez, P. Vestergaard, X. Nogués, 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

The relationship between microbiology results in the second of a two-stage exchange procedure using cement spacers and the outcome after revision total joint replacement for infection: the use of sonication to aid bacteriological analysis.

A. Alier, L. Puig, J. Horcajada, 2012, The Journal of bone and joint surgery. British volume.

Safety of Switching Nevirapine Twice Daily to Nevirapine Once Daily in Virologically Suppressed Patients

D. Podzamczer, E. Negredo, J. Pineda, 2009, Journal of acquired immune deficiency syndromes.

Sexually transmitted infections in young people and factors associated with HIV coinfection: an observational study in a large city

J. Caylà, M. Alsina, M. Gurguí, 2019, BMJ Open.

Epidemiology of infections by HIV, Syphilis, Gonorrhea and Lymphogranuloma Venereum in Barcelona City: a population-based incidence study

J. Miro, J. Caylà, E. Ribera, 2015, BMC Public Health.

High Sensitivity C-Reactive Protein and Response to Highly Active Antiretroviral Therapy in Women with HIV-1 Infection

C. Richart, M. Broch, F. Vidal, 2006, Journal of acquired immune deficiency syndromes.

Short Communication: Maraviroc Once-Daily: Experience in Routine Clinical Practice.

D. Podzamczer, J. Arribas, A. Rivero, 2016, AIDS research and human retroviruses.

Evaluation of the safety and effectiveness of nevirapine plus coformulated tenofovir/emtricitabine as first-line therapy in routine clinical practice.

J. Mallolas, E. Ferrer, E. Pedrol, 2012, AIDS research and human retroviruses.

Hepatotoxicity of nevirapine in virologically suppressed patients according to gender and CD4 cell counts *

J. Montaner, B. Clotet, E. Negredo, 2008, HIV medicine.

Liver Toxicity of Initial Antiretroviral Drug Regimens Including Two Nucleoside Analogs Plus One Non-Nucleoside Analog or One Ritonavir-Boosted Protease Inhibitor in HIV/HCV-Coinfected Patients

B. Clotet, J. Mallolas, J. Macías, 2012, HIV clinical trials.

Risk of side effects associated with the use of nevirapine in treatment‐naïve patients, with respect to gender and CD4 cell count

S. Luque, H. Knobel, A. Guelar, 2008, HIV medicine.

Toxoplasmic encephalitis with normal CT scan and pathologic MRI.

J. Miro, F. Graus, H. Knobel, 1995, The American journal of medicine.

Concomitant nevirapine therapy is associated with higher efficacy of pegylated interferon plus ribavirin among HIV/hepatitis C virus-coinfected patients.

C. Tural, M. Laguno, M. Crespo, 2010 .

Risk of cardiovascular disease in patients with HIV infection undergoing antiretroviral therapy

J. Blanco, A. Antela, R. Palacios, 2020 .

Comparison of hospitalized COVID-19 and influenza patients requiring supplemental oxygen in a cohort study: clinical impact and resource consumption

E. Cañas-Ruano, X. Nogués, I. Arnau-Barrés, 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Increased Indoleamine-2,3-Dioxygenase Activity Is Associated With Poor Clinical Outcome in Adults Hospitalized With Influenza in the INSIGHT FLU003Plus Study

T. Griffin, R. Dewar, J. Metcalf, 2017, Open forum infectious diseases.

Inflammation status in HIV-positive individuals correlates with changes in bone tissue quality after initiation of ART

A. Díez-Pérez, T. Brown, N. Garcia-Giralt, 2019, The Journal of antimicrobial chemotherapy.

PD-L1 Blockade Differentially Impacts Regulatory T Cells from HIV-Infected Individuals Depending on Plasma Viremia

Felipe García, M. Plana, A. Meyerhans, 2015, PLoS pathogens.

Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir/Abacavir/Lamivudine in Antiretroviral-Naive Adults (SYMTRI): A Multicenter Randomized Open-Label Study (PReEC/RIS-57)

D. Podzamczer, E. Ribera, J. Macías, 2021, Open forum infectious diseases.

Comparison of the Outcomes of Individuals With Medically Attended Influenza A and B Virus Infections Enrolled in 2 International Cohort Studies Over a 6-Year Period: 2009–2015

R. Schooley, E. Maltezos, Tak-chiu Wu, 2017, Open forum infectious diseases.

Dynamics of creatinine estimated glomerular filtration rate using one or more antiretrovirals that inhibit creatinine tubular secretion.

E. Negredo, E. Martinez, J. De La Torre, 2021, The Journal of antimicrobial chemotherapy.

Osteopenia in HIV-infected patients: is it the disease or is it the treatment?

X. Nogués, H. Knobel, A. Diez, 2001, AIDS.

Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a retrospective cohort study

Miguel Ángel Martínez, D. Podzamczer, J. Mallolas, 2021, The Lancet HIV.

Costs and cost-efficacy analysis of the 2016 GESIDA/Spanish AIDS National Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults.

J. Gatell, J. De La Torre, M. Crespo, 2017, Enfermedades infecciosas y microbiologia clinica.

Costs and cost-effectiveness analysis of 2015 GESIDA/Spanish AIDS National Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults.

D. Podzamczer, B. Clotet, J. Miro, 2017, Enfermedades infecciosas y microbiologia clinica.

National Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults

D. Podzamczer, B. Clotet, J. Miro, 2016 .

D. Podzamczer, J. Gatell, A. Rivero, 2015 .

[Costs and cost-efficacy analysis of the preferred treatments by GESIDA/National Plan for AIDS for the initial antiretroviral therapy in adult human immunodeficiency virus (HIV) infected patients in 2012].

D. Podzamczer, B. Clotet, J. Miro, 2012, Enfermedades infecciosas y microbiologia clinica.

Moisturizing body milk as a reservoir of Burkholderia cepacia: outbreak of nosocomial infection in a multidisciplinary intensive care unit

P. Coll, A. Vázquez, C. Segura, 2008, Critical care.

Osteoarticular Cryptococcosis Successfully Treated with High-Dose Liposomal Amphotericin B Followed by Oral Fluconazole

E. Letang, N. Campillo, J. Horcajada, 2021, Infection and drug resistance.

Prevention and treatment of opportunistic infections and other coinfections in HIV-infected patients: May 2015.

D. Podzamczer, J. Mallolas, J. Caylà, 2016, Enfermedades infecciosas y microbiologia clinica.

Consensus document on the management of renal disease in HIV-infected patients.

E. Negredo, J. Miro, E. Martinez, 2014, Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia.

[Candidemia in AIDS. A retrospective study of nine cases].

J. M. Torres-Rodríguez, M. Salvadó, H. Knobel, 2000, Revista iberoamericana de micologia.

Factors associated to neurocognitive impairment in older adults living with HIV

I. Arnau-Barrés, H. Knobel, R. Güerri-Fernández, 2022, European Journal of Medical Research.

Executive summary: Prevention and treatment of opportunistic infections and other coinfections in HIV-infected patients: May 2015.

D. Podzamczer, J. Mallolas, J. Caylà, 2016, Enfermedades infecciosas y microbiologia clinica.

Trough colistin plasma level is an independent risk factor for nephrotoxicity: a prospective observational cohort study

S. Luque, J. Horcajada, C. Segura, 2013, BMC Infectious Diseases.

Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials

B. Gazzard, K. Tashima, M. Shields, 2019, The Lancet.

Comparison of twice-daily stavudine plus once- or twice-daily didanosine and nevirapine in early stages of HIV infection: the Scan Study

J. Romeu, Felipe García, A. Cruceta, 2000, AIDS.

Analysis of the costs and cost-effectiveness of the guidelines recommended by the 2018 GESIDA/Spanish National AIDS Plan for initial antiretroviral therapy in HIV-infected adults.

E. Negredo, J. Miro, J. Gatell, 2019, Enfermedades infecciosas y microbiologia clinica.

Impact of adherence and highly active antiretroviral therapy on survival in HIV-infected patients.

Joan A. Caylà, J. Caylà, H. Knobel, 2002 .

A randomized study comparing triple versus double antiretroviral therapy or no treatment in HIV-1-infected patients in very early stage disease: the Spanish Earth-1 study.

D. Podzamczer, B. Clotet, J. Romeu, 1999, AIDS.

Barriers to health care services for migrants living with HIV in Spain

J. Miro, B. Ledergerber, E. Fernández, 2018, European journal of public health.

Mortality, Causes of Death and Associated Factors Relate to a Large HIV Population-Based Cohort

J. Miro, J. Gatell, J. Caylà, 2015, PloS one.

CD4 count and viral load time‐courses in patients treated with highly active antiretroviral therapy and association with the CDC staging system

J. Casado, H. Knobel, J. Collazos, 2006, HIV medicine.

Treatment of hepatitis C HIV-coinfected patients with interferon: Controlled study

H. Knobel, R. Solà, J. Gimeno, 2000 .

Three-year follow-up of protease inhibitor-based regimen simplification in HIV-infected patients

D. Podzamczer, J. Gatell, E. Martinez, 2007, AIDS.

Effectiveness of antiretroviral therapy in HIV-1-infected active drug users attended in a drug abuse outpatient treatment facility providing a multidisciplinary care strategy.

K. Langohr, M. Torrens, J. Llibre, 2012, Current HIV research.

Effectiveness of a Pilot Partner Notification Program for New HIV Cases in Barcelona, Spain

J. Caylà, È. Díez, M. Barberá, 2015, PloS one.

Effectiveness and safety of an abacavir/lamivudine + rilpivirine regimen for the treatment of HIV-1 infection in naive patients.

D. Podzamczer, E. Martinez, A. Curran, 2016, The Journal of antimicrobial chemotherapy.

Dual treatment with lopinavir-ritonavir plus lamivudine versus triple treatment with lopinavir-ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): a randomised, open-label, non-inferiority trial.

D. Podzamczer, J. Gatell, J. Mallolas, 2015, The Lancet. Infectious diseases.

Use of Non-Nucleoside Analogues Together with Rifampin in HIV Patients with Tuberculosis

L. Sorlí, H. Knobel, A. Guelar, 2011, HIV clinical trials.

Substitution of raltegravir for ritonavir-boosted protease inhibitors in HIV-infected patients: the SPIRAL study

J. Gatell, E. Martinez, M. Larrousse, 2010, AIDS.

Post-Exposure Prophylaxis for HIV Infection: A Clinical Trial Comparing Lopinavir/Ritonavir versus Atazanavir Each with Zidovudine/Lamivudine

B. Clotet, Felipe García, A. Cruceta, 2012, Antiviral therapy.

Validation of a simplified medication adherence questionnaire in a large cohort of HIV-infected patients: the GEEMA Study

J. Casado, A. Ocampo, J. M. Kindelán, 2002, AIDS.

Epidemiological characteristics and predictors of late presentation of HIV infection in Barcelona (Spain) during the period 2001-2009

J. Miro, J. Caylà, P. Domingo, 2011, AIDS research and therapy.

Mortality of COPD Patients Infected with Multi-Resistant Pseudomonas aeruginosa: A Case and Control Study

M. Salvadó, H. Knobel, M. Orozco-Levi, 2009, Infection.

Eosinophil Count and Neutrophil-Lymphocyte Count Ratio as Prognostic Markers in Patients with Bacteremia: A Retrospective Cohort Study

X. Castells, J. Horcajada, H. Knobel, 2012, PloS one.

Thrice-Weekly Sulfadiazine-Pyrimethamine for Maintenance Therapy of Toxoplasmic Encephalitis in HIV-Infected Patients

D. Podzamczer, A. Cruceta, J. Miro, 2000, European Journal of Clinical Microbiology and Infectious Diseases.

Effectiveness and safety of colistin for the treatment of multidrug-resistant Pseudomonas aeruginosa infections

M. Sala, J. Horcajada, H. Knobel, 2009, Infection.

Impact of the COVID-19 pandemic: Community and hospital shared pharmaceutical care model. Satisfaction and acceptability of patients with HIV infection on antiretroviral treatment

S. Luque, H. Knobel, S. Grau, 2021, Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia.

A novel whole-blood miRNA signature for a rapid diagnosis of pulmonary tuberculosis

Christina Backes, Eckart Meese, Andreas Keller, 2015, European Respiratory Journal.

Impact of different patterns of nonadherence on the outcome of highly active antiretroviral therapy in patients with long‐term follow‐up

H. Knobel, A. Guelar, A. Carmona, 2009, HIV medicine.

[GESIDA/SEFH/PNS recommendations to improve adherence to antiretroviral therapy in 2004].

I. Escobar, F. Segura, J. Casado, 2004, Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria.

Virologic outcome and predictors of virologic failure of highly active antiretroviral therapy containing protease inhibitors.

H. Knobel, A. Diez, J. Gimeno, 2001, AIDS patient care and STDs.

International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK

Raúl Tabarés Gutiérrez, Samit R. Joshi, H. Jessen, 2016, Journal of the International AIDS Society.

Lopinavir-Ritonavir Monotherapy Versus Lopinavir-Ritonavir and 2 Nucleosides for Maintenance Therapy of HIV: 96-Week Analysis

J. Arribas, R. Delgado, M. Pérez-Elías, 2009, Journal of acquired immune deficiency syndromes.

Rate of cardiovascular, renal and bone disease and their major risks factors in HIV-infected individuals on antiretroviral therapy in Spain

J. Blanco, A. Antela, R. Palacios, 2019, Enfermedades infecciosas y microbiologia clinica (English ed.).

Rate of cardiovascular, renal and bone disease and their major risks factors in HIV-infected individuals on antiretroviral therapy in Spain.

J. Blanco, A. Antela, R. Palacios, 2019, Enfermedades infecciosas y microbiologia clinica.

Impact of probiotic Saccharomyces boulardii on the gut microbiome composition in HIV-treated patients: A double-blind, randomised, placebo-controlled trial

A. Artacho, A. Moya, J. Horcajada, 2017, PloS one.

Long-term efficacy and safety of nevirapine-containing regimens in virologically suppressed patients: a 17-year follow up.

D. Podzamczer, P. Domingo, H. Knobel, 2019, HIV research & clinical practice.

International Congress of Drug Therapy in HIV Infection 2‐6 November 2014, Glasgow, UK

Samit R. Joshi, Charlene A Flash, Thomas Lengauer, 2014 .

Substitution of nevirapine, efavirenz, or abacavir for protease inhibitors in patients with human immunodeficiency virus infection.

D. Podzamczer, J. Gatell, E. Martinez, 2003, The New England journal of medicine.

Effectiveness of ritonavir-boosted protease inhibitor monotherapy in the clinical setting: same results as in clinical trials? The PIMOCS Study Group.

D. Podzamczer, E. Martinez, A. Curran, 2014, The Journal of antimicrobial chemotherapy.

Early Virological Failure with a Combination of Tenofovir, Didanosine and Efavirenz

D. Podzamczer, J. Gatell, A. León, 2005, Antiviral therapy.

[Economic impact of nosocomial bacteraemia. A comparison of three calculation methods].

X. Castells, F. Cots, M. Sala, 2016, Enfermedades infecciosas y microbiologia clinica.

Impact of Syphilis Infection on HIV Viral Load and CD4 Cell Counts in HIV-Infected Patients

J. Ena, Jesús Santos, R. Palacios, 2007, Journal of acquired immune deficiency syndromes.

Community-onset healthcare-related urinary tract infections: comparison with community and hospital-acquired urinary tract infections.

J. Horcajada, M. Salvadó, H. Knobel, 2012, Journal of Infection.

“It made me more confident that I have it under control”: Patient and provider perspectives on moving to a two-drug ART regimen in the United States and Spain

D. Ward, M. Murray, U. Bredeek, 2020, PloS one.

Simplified Therapy with Zidovudine, Lamivudine, and Abacavir for Very Nonadherent, Treatment-Failing Patients

E. Pedrol, H. Knobel, A. Carmona, 2004, HIV clinical trials.

Comparison of Antiviral Activity of Regimens Containing Nucleos(t)ide (NUC) Pairs in HIV-Infected Patients Initiating REScue Therapy (The NUCREST Study)

A. Milinkovic, A. Curran, J. Pérez-Molina, 2010, HIV clinical trials.

Protease inhibitors and cardiac autonomic function in HIV-infected patients: a cross-sectional analysis from the Strategies for Management of Antiretroviral Therapy (SMART) Trial

E. Soliman, D. Duprez, M. Roediger, 2013, BMJ Open.

Dual Therapy With Darunavir and Ritonavir Plus Lamivudine vs Triple Therapy With Darunavir and Ritonavir Plus Tenofovir Disoproxil Fumarate and Emtricitabine or Abacavir and Lamivudine for Maintenance of Human Immunodeficiency Virus Type 1 Viral Suppression: Randomized, Open-Label, Noninferiority DU

D. Podzamczer, B. Clotet, E. Negredo, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Outcomes in HIV-infected patients admitted due to pandemic influenza.

F. Lozano, Jesús Santos, H. Knobel, 2012, Enfermedades infecciosas y microbiologia clinica.

Who is lost to follow-up in HIV care? Assessment of care retention over time and the impact of COVID-19. Longitudinal analysis of the PISCIS cohort.

J. Palacio-Vieira, J. Casabona, J. Miró, 2023, HIV medicine.

Primary resistance to integrase strand transfer inhibitors in Spain using ultrasensitive HIV-1 genotyping.

R. Paredes, D. Podzamczer, M. Noguera-Julián, 2020, The Journal of antimicrobial chemotherapy.

Virological failure to raltegravir in Spain: incidence, prevalence and clinical consequences.

R. Paredes, B. Clotet, J. Blanco, 2015, The Journal of antimicrobial chemotherapy.

Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain

D. Podzamczer, J. Blanco, M. Laguno, 2020, Clinical Microbiology and Infection.

Metabolic syndrome among HIV-infected patients: prevalence, characteristics, and related factors.

J. Ordóñez‐Llanos, C. Jericó, H. Knobel, 2005, Diabetes care.

Brief Report: HIV Infection Is Associated With Worse Bone Material Properties, Independently of Bone Mineral Density

A. Díez-Pérez, X. Nogués, L. Mellibovsky, 2016, Journal of acquired immune deficiency syndromes.

Executive summary of the GESIDA/National AIDS Plan Consensus Document on antiretroviral therapy in adults infected by the human immunodeficiency virus (updated January 2015).

D. Podzamczer, B. Clotet, J. Gatell, 2015, Enfermedades Infecciosas y Microbiologia Clinica.

Global cardiovascular risk in patients with HIV infection: concordance and differences in estimates according to three risk equations (Framingham, SCORE, and PROCAM).

C. Jericó, H. Knobel, P. Saballs, 2007, AIDS patient care and STDs.

Hypertension in HIV-infected patients: prevalence and related factors.

C. Jericó, H. Knobel, J. Gimeno, 2005, American journal of hypertension.

Rapid Communications: Failure of a Short‐Term Prednisone Regimen to Prevent Nevirapine‐Associated Rash: A Double‐Blind Placebo‐Controlled Trial: The GESIDA 09/99 Study

J. Miro, J. Blanco, A. Rivero, 2001, Journal of acquired immune deficiency syndromes.

Changes in bone quality after switching from a TDF to a TAF based ART: A pilot randomized study

E. Cañas-Ruano, N. Garcia-Giralt, H. Knobel, 2023, Frontiers in Endocrinology.

Bone density, microarchitecture and tissue quality after 1 year of treatment with dolutegravir/abacavir/lamivudine.

A. Díez-Pérez, T. Brown, N. Garcia-Giralt, 2020, The Journal of antimicrobial chemotherapy.

Correlation between blood telomere length and CD4+ CD8+ T-cell subsets changes 96 weeks after initiation of antiretroviral therapy in HIV-1–positive individuals

A. Samri, B. Autran, J. Blanco, 2020, PloS one.

Correction: Abacavir/Lamivudine plus Rilpivirine Is an Effective and Safe Strategy for HIV-1 Suppressed Patients: 48 Week Results of the SIMRIKI Retrospective Study

D. Podzamczer, E. Ribera, S. Moreno, 2017, PloS one.

Factors associated with the number of drugs in darunavir/cobicistat regimens.

E. Negredo, E. Ribera, M. Pérez-Elías, 2019, The Journal of antimicrobial chemotherapy.

Low-Density Lipoprotein Size and Lipoprotein-Associated Phospholipase A2 in HIV-Infected Patients Switching to Abacavir or Tenofovir

D. Podzamczer, E. Negredo, J. Gatell, 2011, Antiviral therapy.

[The recommendations of GESIDA/SEFH/PNS for improving adherence to antiretroviral treatment. AIDS Study Group of the Spanish Society of Hospital Pharmacy and the National Plan on AIDS of the Minister of Health and Consumers].

J. Miro, A. Antela, P. Viciana, 2000, Enfermedades infecciosas y microbiologia clinica.

Outcomes by sex following treatment initiation with darunavir/cobicistat in a large Spanish cohort of the CODAR study (GeSIDA 9316).

J. M. García de Lomas, J. De La Torre, E. Ribera, 2019, The Journal of antimicrobial chemotherapy.

Multiple myeloma and AIDS

X. Nogués, H. Knobel, A. Supervía, 1996, American journal of hematology.

Cardiovascular events in delayed presentation of HIV: the prospective PISCIS cohort study

J. Burgos, J. Casabona, J. Miró, 2023, Frontiers in Medicine.

LDL subclasses and lipoprotein-phospholipase A2 activity in suppressed HIV-infected patients switching to raltegravir: Spiral substudy.

D. Podzamczer, B. Clotet, J. Gatell, 2012, Atherosclerosis.

Costs and cost-efficacy analysis of the 2014 GESIDA/Spanish National AIDS Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults.

D. Podzamczer, J. Gatell, A. Rivero, 2015, Enfermedades infecciosas y microbiologia clinica.

Executive summary of the consensus document on osteoporosis in HIV-infected individuals.

E. Negredo, E. Martinez, F. Lozano, 2017, Enfermedades infecciosas y microbiologia clinica.

[Barriers to ART initiation in HIV infected subjects and with treatment indication in Spain. Why don't they start their treatment? Bridgap Study].

D. Podzamczer, B. Clotet, V. Falcó, 2015, Enfermedades infecciosas y microbiologia clinica.

Alcohol‐induced bone disease in the absence of severe chronic liver damage

J. Marrugat, X. Nogués, L. Mellibovsky, 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

The Framingham function overestimates the risk of ischemic heart disease in HIV-infected patients from Barcelona

J. Marrugat, J. Vila, M. Grau, 2016, HIV clinical trials.

Frequency and severity of potential drug interactions in a cohort of HIV-infected patients Identified through a Multidisciplinary team

S. Luque, L. Sorlí, H. Knobel, 2018, HIV clinical trials.

Induction therapy with trizivir plus efavirenz or lopinavir/ritonavir followed by trizivir alone in naive HIV-1-infected adults

J. Gatell, J. Mallolas, F. Vidal, 2008, AIDS.

Risk Factors for Mortality among Patients with Pseudomonas aeruginosa Bloodstream Infections: What Is the Influence of XDR Phenotype on Outcomes?

J. Horcajada, C. Segura, H. Knobel, 2020, Journal of clinical medicine.

Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir/Abacavir/Lamivudine in Antiretroviral-Naive Adults (SYMTRI): A Multicenter Randomized Open-Label Study (PReEC/RIS-57)

D. Podzamczer, J. Macías, S. Moreno, 2021, Open forum infectious diseases.

An Abnormal Inflammatory Pattern Associated with Long-Term Non-Progression of HIV Infection Impacts Negatively on Bone Quality

E. Cañas-Ruano, N. Garcia-Giralt, H. Knobel, 2022, Journal of clinical medicine.

Substitution of raltegravir for ritonavir-boosted protease inhibitors in HIV-infected patients: the SPIRAL study

J. Gatell, E. Martinez, M. Larrousse, 2010, AIDS.

Comparison of immunologic restoration and virologic response in plasma, tonsillar tissue, and cerebrospinal fluid in HIV-1-infected patients treated with double versus triple antiretroviral therapy in very early stages: The Spanish EARTH-2 Study. Early Anti-Retroviral Therapy Study.

B. Clotet, J. Romeu, A. Cruceta, 2000, Journal of acquired immune deficiency syndromes.

HIV infection is strongly associated with hip fracture risk, independently of age, gender, and comorbidities: A population‐based cohort study

A. Díez-Pérez, P. Vestergaard, X. Nogués, 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Clinical characteristics and outcomes of patients with vancomycin-susceptible Enterococcus faecalis and Enterococcus faecium bacteraemia in cancer patients

M. Salvadó, H. Knobel, S. Grau, 2010, European Journal of Clinical Microbiology & Infectious Diseases.

Network meta‐analysis of post‐exposure prophylaxis randomized clinical trials

A. Arenas-Pinto, J. Peraire, H. Knobel, 2020, HIV medicine.

Executive summary of the GeSIDA/National AIDS Plan consensus document on antiretroviral therapy in adults infected by the human immunodeficiency virus (updated January 2018).

D. Podzamczer, E. Negredo, J. Miro, 2019, Enfermedades infecciosas y microbiologia clinica.

Switching to Dolutegravir/lamivudine or Bictegravir/Emtricitabine/Tenofovir alafenamide. A comparative real-world study

Pablo Knobel, E. Cañas-Ruano, H. Knobel, 2023, HIV research & clinical practice.

Consensus document on the management of renal disease in HIV-infected patients.

E. Negredo, J. Miro, E. Martinez, 2014, Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia.

Failure of a short-term prednisone regimen to prevent nevirapine-associated rash: a double-blind placebo-controlled trial: the GESIDA 09/99 study.

J. Miro, J. Blanco, A. Rivero, 2001, Journal of acquired immune deficiency syndromes.

Hepatotoxicity of nevirapine in virologically suppressed patients according to gender and CD4 cell counts *

J. Montaner, B. Clotet, E. Negredo, 2008, HIV medicine.

Barriers to health care services for migrants living with HIV in Spain

B. Ledergerber, E. Fernández, G. Touloumi, 2018, European journal of public health.

[Acceptance of, compliance with and tolerance to antiretroviral treatment in patients with human immunodeficiency virus infection].

M. Pavesi, H. Knobel, A. Diez, 1997, Anales de medicina interna.